These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 16002671)

  • 1. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.
    Alves NL; Arosa FA; van Lier RA
    J Immunol; 2005 Jul; 175(2):755-62. PubMed ID: 16002671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new subset of human naive CD8+ T cells defined by low expression of IL-7R alpha.
    Alves NL; van Leeuwen EM; Remmerswaal EB; Vrisekoop N; Tesselaar K; Roosnek E; ten Berge IJ; van Lier RA
    J Immunol; 2007 Jul; 179(1):221-8. PubMed ID: 17579041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes.
    Gagnon J; Ramanathan S; Leblanc C; Cloutier A; McDonald PP; Ilangumaran S
    J Immunol; 2008 Jun; 180(12):7958-68. PubMed ID: 18523259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response.
    Demirci G; Gao W; Zheng XX; Malek TR; Strom TB; Li XC
    J Immunol; 2002 May; 168(9):4382-90. PubMed ID: 11970980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span.
    Nguyen H; Weng NP
    J Leukoc Biol; 2010 Jan; 87(1):43-9. PubMed ID: 19797296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice.
    Tsark EC; Dao MA; Wang X; Weinberg K; Nolta JA
    J Immunol; 2001 Jan; 166(1):170-81. PubMed ID: 11123290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.
    Li Y; Bleakley M; Yee C
    J Immunol; 2005 Aug; 175(4):2261-9. PubMed ID: 16081794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
    Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
    J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
    Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
    J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
    Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells.
    Valenzuela J; Schmidt C; Mescher M
    J Immunol; 2002 Dec; 169(12):6842-9. PubMed ID: 12471116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.
    Labalette M; Leteurtre E; Thumerelle C; Grutzmacher C; Tourvieille B; Dessaint JP
    Int Immunol; 1999 Aug; 11(8):1327-36. PubMed ID: 10421790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CD28 costimulation in human CD8+ T cells.
    Lloyd TE; Yang L; Tang DN; Bennett T; Schober W; Lewis DE
    J Immunol; 1997 Feb; 158(4):1551-8. PubMed ID: 9029089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.
    Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G
    J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.